Summary of a workshop on the implementation of NAT to screen donors of blood and plasma for viruses

Summary of a workshop on the implementation of NAT to screen donors of blood and plasma for viruses A workshop on the implementation of NAT to screen donors of blood and plasma for viruses, sponsored by the FDA, was held on December 14, 1999, in Bethesda, MD. Participants included representatives from companies that are testing donations of blood and plasma under investigational new drug exemptions (INDs), representatives of blood and plasma trade organizations, foreign regulatory and public health officials, and FDA staff members. The goal of the workshop was to discuss the issues and progress in implementing NAT to detect viruses in blood and plasma, including HCV, HIV‐1, HBV, and parvovirus B19. An earlier workshop, in 1998, had addressed many aspects of NAT screening for HCV. At the present workshop, industry representatives reported a projection that >99 percent of whole blood and source plasma collected in the United States would be tested in minipools by NAT for both HCV and HIV‐1 by the end of 1999. In actuality, 99 percent of source plasma and >95 percent of whole blood were being tested by NAT for both HCV and HIV‐1 by the end of 1999. In the United States at the present time, pool sizes for NAT screening of source plasma range from 96 to 1200 units http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Transfusion Wiley

Summary of a workshop on the implementation of NAT to screen donors of blood and plasma for viruses

Loading next page...
 
/lp/wiley/summary-of-a-workshop-on-the-implementation-of-nat-to-screen-donors-of-e21cbcHbkZ
Publisher
Wiley
Copyright
Copyright © 2000 Wiley Subscription Services
ISSN
0041-1132
eISSN
1537-2995
D.O.I.
10.1046/j.1537-2995.2000.40101273.x
Publisher site
See Article on Publisher Site

Abstract

A workshop on the implementation of NAT to screen donors of blood and plasma for viruses, sponsored by the FDA, was held on December 14, 1999, in Bethesda, MD. Participants included representatives from companies that are testing donations of blood and plasma under investigational new drug exemptions (INDs), representatives of blood and plasma trade organizations, foreign regulatory and public health officials, and FDA staff members. The goal of the workshop was to discuss the issues and progress in implementing NAT to detect viruses in blood and plasma, including HCV, HIV‐1, HBV, and parvovirus B19. An earlier workshop, in 1998, had addressed many aspects of NAT screening for HCV. At the present workshop, industry representatives reported a projection that >99 percent of whole blood and source plasma collected in the United States would be tested in minipools by NAT for both HCV and HIV‐1 by the end of 1999. In actuality, 99 percent of source plasma and >95 percent of whole blood were being tested by NAT for both HCV and HIV‐1 by the end of 1999. In the United States at the present time, pool sizes for NAT screening of source plasma range from 96 to 1200 units

Journal

TransfusionWiley

Published: Jan 1, 2000

Keywords: ; ; ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off